Advertisement

Topics

Johnson & Johnson Increases Sales Guidance; Plans Supply Chain Actions

07:19 EDT 17 Apr 2018 | FinanzNachrichten

NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) increased its sales guidance for the full-year 2018 to a range of $81.0 to $81.8 billion, reflecting expected operational growth in the range of 4...

Original Article: Johnson & Johnson Increases Sales Guidance; Plans Supply Chain Actions

NEXT ARTICLE

More From BioPortfolio on "Johnson & Johnson Increases Sales Guidance; Plans Supply Chain Actions"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...